Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 48:93-102, April 2007
doi: 10.1176/appi.psy.48.2.93
© 2007 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Jones, M. P.
* Articles by Creed, F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Jones, M. P.
* Articles by Creed, F.
Related Collections
* Primary Care
* Somatoform Disorders
* Syndromes Secondary to General Medical Disorders

Review

Functional Gastrointestinal Disorders: An Update for the Psychiatrist

Michael P. Jones, M.D., Michael D. Crowell, Ph.D., Kevin W. Olden, M.D., and Francis Creed, M.D., F.Med.Sci.

Received February 27, 2006; revised May 8, 2006; accepted June 13, 2006. From the Feinberg School of Medicine, Northwestern University, Chicago, IL; Mayo Clinic College of Medicine, Scottsdale, AZ; Univ. of South Alabama, Mobile, AL; and Manchester Royal Infirmary, Manchester, UK. Send correspondence and reprint requests to Michael P. Jones, M.D., 251 East Huron St., Galter Pavilion 4-104, Chicago, IL 60611-2908. e-mail: mpjones{at}nmh.org

Functional gastrointestinal disorders (FGID) are common conditions, with well-established diagnostic criteria. They are associated with impaired health-related quality of life and increased societal and healthcare costs. Their symptoms are probably related to altered 5-HT transmission and central processing of noxious visceral stimuli. Evaluation and treatment are best formulated using a biopsychosocial model that integrates gut function with psychosocial assessment. Psychological therapies may improve overall well-being and appear to help patients without significant psychiatric comorbidity. Antidepressants help comorbid anxiety and depressive disorders and have primary efficacy in improving the symptoms of FGID. Finally, there is a need for greater involvement of psychiatrists in both the evaluation and treatment of patients with FGID as well as the education and training of practitioners caring for these patients.







Get information about faster international access.

Privacy Policy

Copyright © 2007 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org